Mutations in the DLG3 Gene Cause Nonsyndromic X-Linked Mental Retardation
Patrick Tarpey(Wellcome Sanger Institute), F. Lucy Raymond(University of Cambridge), Andrew J. Donnelly(The University of Adelaide), James J. Cox(University College London), Jozef Gécz(The University of Adelaide), Matthew J. Blow(Wellcome Sanger Institute), Simon Holden(Addenbrooke's Hospital), Adrian G. Parker(Wellcome Sanger Institute), M. W. Partington(University of King's College), Marie Mangelsdorf(Women's and Children's Hospital), Gillian Turner(Hunter Genetics), John C. Mulley(The University of Adelaide), Douglas F. Easton(University of Cambridge), Michael R. Stratton(Wellcome Sanger Institute), Graham R. Bignell(Lund University), P. Andrew Futreal(Wellcome Sanger Institute), Martin Bobrow, Ian Young(Toronto Public Health), Charles E. Schwartz(Greenwood Genetic Center), Hayley Woffendin(Wellcome Sanger Institute), Uma Mallya, Helen Davies(German Cancer Research Center), Angelique Korny(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Roger E. Stevenson(Greenwood Genetic Center), Claire Stevens(Wellcome Sanger Institute), Richard Wooster(Institute of Cancer Research), Charles Cox(The University of Texas Health Science Center at Houston), Jenny Moon, Sarah O’Meara(Wellcome Sanger Institute), Sarah Edkins(Wellcome Sanger Institute), Philip Stephens(Wellcome Sanger Institute), Josep Parnau
Cited by 176
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
The cancer genome
|Nature|2009|3.5k